The biomedical industry is constantly exploring for innovative methods to optimize drug discovery. Azoisobutyronitrile (AIBN), a frequently used radical initiator, has emerged as a viable candidate in this endeavor. https://vinnyptlq169554.aboutyoublog.com/profile